超声造影预测肝细胞癌根治性切除术后早期复发并分层早期复发风险:一项回顾性观察性研究
该回顾性观察性研究纳入2011年1月至2018年12月根治性切除前2周内接受超声造影检查的连续556例肝细胞癌患者,早期复发定义为切除术后2年内肝内和/或肝外复发。多因素分析显示超声造影所见肿瘤大小≥30 mm、卫星结节、基于超声造影最大强度帧的深度学习影像组学复发评分及甲胎蛋白升高与早期复发显著相关,据此将超声造影LR-5肝细胞癌患者分为3个风险组,2年无复发生存率分别为19.4%、40.9%和48.1%。
要点
- 超声造影所见肿瘤大小≥30 mm和卫星结节是肝细胞癌根治性切除术后早期复发的独立预测因素。
- 基于超声造影最大强度帧的深度学习影像组学复发评分及甲胎蛋白升高亦与早期复发显著相关。
- 按预测因素数目将超声造影LR-5肝细胞癌患者分为3个风险组,2年无复发生存率分别为19.4%、40.9%和48.1%。
核心结论
- 超声造影所见肿瘤大小≥30 mm、卫星结节、基于超声造影最大强度帧的深度学习影像组学复发评分及甲胎蛋白升高可预测肝细胞癌根治性切除术后早期复发,并据此对超声造影LR-5肝细胞癌患者进行早期复发风险分层。
研究设计与样本
- 回顾性观察性研究,纳入2011年1月至2018年12月根治性切除前2周内接受超声造影检查的连续556例肝细胞癌患者,早期复发定义为切除术后2年内肝内和/或肝外复发,采用单因素及逻辑回归分析筛选独立危险因素,用log-rank检验比较无复发生存率。
诊断标准与关键数值
- 早期复发定义为肝细胞癌切除术后2年内肝内和/或肝外复发;多因素分析显示肿瘤大小≥30 mm、超声造影所见卫星结节、基于超声造影最大强度帧的深度学习影像组学复发评分及甲胎蛋白升高与早期复发显著相关(P < .05)。
临床应用与阅片要点
- 基于预测因素数目将超声造影LR-5肝细胞癌患者分为3个风险组:风险组3(高危患者,4个预测因素)、风险组2(中危患者,2-3个预测因素)、风险组1(低危患者,0-1个预测因素)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Early recurrence (ER) after surgery is related to early death in patients with hepatocellular carcinoma (HCC) after radical resection. To explore the role of preoperative contrast-enhanced ultrasound (CEUS) in predicting ER of HCC after curative resection and to stratify the risk of ER.
MATERIALS AND METHODS: This study evaluated consecutive 556 patients with HCC who were examined by CEUS during the 2 weeks before curative resection between January 2011 and December 2018. ER was defined as intrahepatic and/or extrahepatic recurrence within 2 year after resection of HCC. Univariate and logistic regression analyses were performed to identify independent risk factors for ER after surgical resection of HCC. Recurrence-free time (RFS) rates were analyzed and compared by log-rank test.
RESULTS: ER occurred in 307 (55.2%) of the 556 patients. Univariate and multivariate analyses revealed that a tumor size ≥ 30 mm and satellite nodules seen on CEUS, DL(deep learning) radiomics reoccurrence score based on the frame of image with the maximum intensity of CEUS and an elevated alpha-fetoprotein level were significantly associated with ER (P < .05). Based on the number of predictors present, patients with CEUS LR-5 HCC were stratified into three risk subgroups: risk group 3 (high-risk patients, 4 predictors), risk group 2 (medium-risk patients, 2-3 predictors), and risk group 1 (low-risk patients, 0-1 predictor). The 2-year RFS rate was 19.4% in risk group 3, 40.9% in risk group 2, and 48.1% in risk group 1; the corresponding mean RFS times were 14.0 ± 2.9 months, 43.7 ± 6.6 months, and 55.5 ± 2.8 months, respectively (P < .001).
CONCLUSIONS: Tumor size ≥ 30 mm and satellite nodules seen on CEUS, DL radiomics reoccurrence score based on the frame of image with the maximum intensity of CEUS and an elevated alpha-fetoprotein level can predict ER of HCC.
引用
- Huang Z, Zhu RH, Li SS, et al. CEUS in prediction of early recurrence of hepatocellular carcinoma after curative resection and to stratify the risk of early recurrence: a retrospective observational study. Abdom Radiol (NY). 2024. PMID: 38557770. doi:10.1007/s00261-024-04252-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。